Society ❯ Health Issues ❯ Obesity ❯ Weight Management

Drug Accessibility

U.S. Strikes Price-Cut Deals With Novo Nordisk and Eli Lilly for GLP‑1s, With Medicare Pilot in 2026

Unsettled rules, pending FDA decisions, insurer responses and state opt-ins signal a staggered 2026 rollout.

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide